| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Giovanna Dal Bello | Q84676123 |
| Simona Coco | Q50638967 | ||
| Carlo Genova | Q52665527 | ||
| Francesco Grossi | Q52665537 | ||
| Irene Vanni | Q55283703 | ||
| Anna Truini | Q56979717 | ||
| Angela Alama | Q67233550 | ||
| P2093 | author name string | Francesco Boccardo | |
| Erika Rijavec | |||
| Giulia Barletta | |||
| Federica Biello | |||
| Claudia Maggioni | |||
| Sabrina Beltramini | |||
| Maria Attilia Grassi | |||
| P2860 | cites work | Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors | Q24319747 |
| Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells | Q24601584 | ||
| Allogeneic tumor cell vaccines: the promise and limitations in clinical trials | Q26852333 | ||
| A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatment | Q26862558 | ||
| Biomarkers and correlative endpoints for immunotherapy trials | Q27003328 | ||
| Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System | Q27004790 | ||
| Sipuleucel-T immunotherapy for castration-resistant prostate cancer | Q27860648 | ||
| Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer | Q29616379 | ||
| Cancer immunotherapy comes of age | Q29619918 | ||
| TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition | Q33734595 | ||
| Nivolumab in NSCLC: latest evidence and clinical potential | Q34466452 | ||
| Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer | Q34762770 | ||
| Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles. | Q35756439 | ||
| Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one. | Q35886889 | ||
| The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors | Q35975387 | ||
| Role of immunotherapy in the treatment of advanced non-small-cell lung cancer. | Q38170384 | ||
| 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up | Q38190426 | ||
| Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy. | Q38202161 | ||
| Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients | Q38207923 | ||
| Antigen-specific vaccines for cancer treatment | Q38284692 | ||
| A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients | Q38999683 | ||
| Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma | Q39907334 | ||
| Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial | Q40308348 | ||
| TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance | Q40351779 | ||
| TG4010: A therapeutic vaccine against MUC1 expressing tumors | Q41819414 | ||
| Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial | Q44991597 | ||
| Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. | Q47829371 | ||
| Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy. | Q50954469 | ||
| Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients. | Q51768350 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1371-1379 | |
| P577 | publication date | 2015-07-27 | |
| P1433 | published in | Expert Opinion on Biological Therapy | Q5421201 |
| P1476 | title | Belagenpumatucel-L for the treatment of non-small cell lung cancer | |
| P478 | volume | 15 |
Search more.